SCHEMBL6162730

SCHEMBL6162730

CCCN1C(=O)CC(=O)N(CCC)C1=S

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
ATM Q13315 1/20 0.35
CYP19A1 P11511 3/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
GAA P10253 3/20 0.33
USP2 O75604 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 5/20 0.32
THRB P10828 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TNFRSF1A P19438 3/20 0.32
NPC1 O15118 2/20 0.32
MAPK1 P28482 2/20 0.32
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11872002 0.90 MAPT (0.33) MAPTATMCYP19A1KDM4EMEN1
SCHEMBL145408 0.87 KDM4E (0.46) MAPTCYP19A1KDM4EMEN1KMT2A
SCHEMBL8652814 0.85 MGLL (0.47) MAPTCYP19A1KDM4EMEN1KMT2A
SCHEMBL12101786 0.84 MGLL (0.46) MAPTCYP19A1KDM4EMEN1KMT2A
SCHEMBL5570285 0.84 MGLL (0.50) MAPTCYP19A1KDM4EMEN1KMT2A
SCHEMBL678530 0.81 MAPT (0.48) MAPTCYP19A1KDM4EMEN1KMT2A
SCHEMBL1033205 0.81 F2 (0.43) MAPTKDM4EMEN1KMT2AHTT
SCHEMBL11868886 0.78 KDM4E (0.43) MAPTCYP19A1KDM4EMEN1KMT2A
SCHEMBL24683243 0.77 KMT2A (0.35) MAPTKDM4EMEN1KMT2AGAA
SCHEMBL24682246 0.77 CARM1 (0.34) MAPTMEN1KMT2AGAAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977545-B1 THE USE OF 1-SUBSTITUTED ISATINS TO DYE FIBERS CONTAINING KERATIN HENKEL KGAA (DE) 2005-02-16 EP claimed
EP-1037586-B1 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KGAA (DE) 2004-12-22 EP claimed
US-6371993-B1 HAIR DYES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2002-04-16 US claimed
US-11031630-B2 Electrolyte and electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2021-06-08 US disclosed
US-20200243906-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200243906-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE CACNA1B, NCS1, CA3 MAPT 1360/4885ATM 2941/4885CYP19A1 1274/4885
US-11031630-B2 Electrolyte and electrochemical device CACNA1B, NCS1, CA3 MAPT 1360/4885ATM 2941/4885CYP19A1 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.